Authors
Loading...
Supports ACM evaluation in gene-elusive endurance athletes with CAD and RV abnormalities; leaves open need for prospective validation.
Key points are not available for this paper at this time.
Tramer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: